Registered entities
CANDEL THERAPEUTICS, INC.
Reg. No. 1841387United States
Candel Therapeutics, Inc
Reg. No. 001-40629United States
Innovation
8 patent families — focus: Human necessities, Chemistry & metallurgy; filing pace steady. Cited 55 times.
| Year | Filings |
|---|---|
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 3 |
| 2024 | 2 |
| 2025 | 4 |
| 2026 | 1 |
Social engagement
Social engagement: 13.1K social following, 7 posts in the last 12 months — around the industry typical range.
Investor mix
6 investors on record; lead investors include PBM Capital.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 50% |
| Private equity | 1 | 17% |
| Other / undisclosed | 2 | 33% |
Hiring activity
Hires periodically
5 roles tracked across 4 of the last 12 months
24 Jun 2026 · Senior Director, QC Laboratory · Needham, Massachusetts
23 Jun 2026 · Senior Scientist I, Quality Control · Needham, Massachusetts
13 Mar 2026 · Clinical Scientist · Needham
6 Feb 2026 · Staff Accountant · Needham
27 Jan 2026 · Manufacturing Specialist, External Manufacturing Quality- Contract · Needham
Based on job postings tracked across public sources.
Recent activity
1 Jul 2026
Milestone
regulatory
25 Jun 2026
Leadership hire
Chief Commercial Officer
24 Jun 2026
Event
2026 Society for Immunotherapy of Cancer (SITC) Biotech Strategic Meeting